GBIO
Price
$6.01
Change
+$0.01 (+0.17%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
40.41M
64 days until earnings call
MGNX
Price
$1.73
Change
-$0.04 (-2.26%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
111.87M
70 days until earnings call
Interact to see
Advertisement

GBIO vs MGNX

Header iconGBIO vs MGNX Comparison
Open Charts GBIO vs MGNXBanner chart's image
Generation Bio
Price$6.01
Change+$0.01 (+0.17%)
Volume$2.43K
Capitalization40.41M
MacroGenics
Price$1.73
Change-$0.04 (-2.26%)
Volume$5.49K
Capitalization111.87M
GBIO vs MGNX Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. MGNX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (GBIO: $6.00 vs. MGNX: $1.77)
Brand notoriety: GBIO and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 22% vs. MGNX: 97%
Market capitalization -- GBIO: $40.41M vs. MGNX: $111.87M
GBIO [@Biotechnology] is valued at $40.41M. MGNX’s [@Biotechnology] market capitalization is $111.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, GBIO is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 2 TA indicator(s) are bullish while MGNX’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 2 bullish, 6 bearish.
  • MGNX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а -6.98% price change this week, while MGNX (@Biotechnology) price change was +4.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($112M) has a higher market cap than GBIO($40.4M). GBIO (-43.396) and MGNX (-45.538) have similar YTD gains . MGNX has higher annual earnings (EBITDA): -26.91M vs. GBIO (-69.92M). MGNX has more cash in the bank: 176M vs. GBIO (141M). MGNX has less debt than GBIO: MGNX (37.2M) vs GBIO (85.3M). MGNX has higher revenues than GBIO: MGNX (164M) vs GBIO (21.2M).
GBIOMGNXGBIO / MGNX
Capitalization40.4M112M36%
EBITDA-69.92M-26.91M260%
Gain YTD-43.396-45.53895%
P/E RatioN/AN/A-
Revenue21.2M164M13%
Total Cash141M176M80%
Total Debt85.3M37.2M229%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOMGNX
RSI
ODDS (%)
Bearish Trend 5 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEGN34.730.36
+1.05%
Legend Biotech Corp
HDB71.160.04
+0.06%
HDFC Bank Limited
SPIR9.04-0.07
-0.77%
Spire Global
KRP13.97-0.13
-0.92%
Kimbell Royalty Partners LP
NEPH3.73-0.30
-7.44%
Nephros